SGLT2 Inhibitors LENGTHEN Telomeres & Stop Cellular Aging (2025 Study) скачать в хорошем качестве

SGLT2 Inhibitors LENGTHEN Telomeres & Stop Cellular Aging (2025 Study)

What if a common diabetes pill could actually reverse cellular aging? New 2025 research reveals that SGLT2 inhibitors don't just control blood sugar—they actively lengthen telomeres and halt senescent cells from accumulating in your body. This changes everything we thought about aging intervention. In this video, we break down the groundbreaking studies showing how SGLT2 inhibitors reduce oxidative stress, protect telomere length in human subjects, and inhibit cellular senescence across multiple tissue types. We explore why scientists now consider this the first FDA-approved drug class with direct anti-aging mechanisms, and what this means for the future of longevity medicine and senotherapeutic treatments. Subscribe to Longevity Labs for weekly deep dives into the latest anti-aging science, longevity protocols, and healthspan breakthroughs. Hit the bell so you never miss a video that could add years to your life. CHAPTERS 00:00 The Hidden Power of Diabetes Drugs 01:09 Telomere Miracle: Growing Back DNA Protection 02:41 Battling Senescence: Clearing Zombie Cells 04:13 Mouse Longevity Proof and Human Trials 05:46 Future of Multi-Drug Longevity Cocktails 07:18 What This Means for Your Healthspan